logo

For the Inventor, By the Inventor

Silver Spring, MD, United States of America

United Therapeutics Corporation


USPTO Granted Patents = 126



Trademarks = 14

Forward Citations = 2,573

Loading Chart...
Loading Chart...

106 inventors (with patents filed for the assignee):

goldMedal Hitesh Batra (33 out of 45 patents)

silverMedal Roger Jeffs (22 out of 22 patents)

bronzeMedal Michael Wade (20 out of 21 patents)

4.  Ken Phares (17 out of 17 patents)

5.  David A Walsh (17 out of 20 patents)

6.  Sudersan M Tuladhar (16 out of 26 patents)

7.  Liang Guo (15 out of 24 patents)

8.  Raju A Penmasta (15 out of 27 patents)

9.  David Mottola (13 out of 13 patents)

10.  Thomas Petersen (12 out of 14 patents)

11.  Roger M Ilagan (12 out of 20 patents)

12.  Vijay Sharma (8 out of 15 patents)

13.  Kenneth R Phares (8 out of 14 patents)

14.  Raymond A Dwek (7 out of 62 patents)

15.  Lewis J Rubin (7 out of 9 patents)


Core Competencies:
Automated Bioreactor
Treprostinil Prodrugs
Pulmonary Arterial Hypertension
Drug Delivery Device
Prostacyclin Analog Delivery
Controlled Release Formulations
Mesenchymal Stem Cells
Aerosol Delivery Device
Antibody Purification
Esuberaprost Synthesis
Vasculopathy Treatment
Extracellular Vesicles

126 patents:

1. 12491170 - Stable treprostinil prodrugs (2025-12-09),
2. 12458015 - Automated bioreactor system, system for automatically implementing protocol for decellularizing organ, and waste decontamination system (2025-11-04),
3. 12397895 - Structural features of a vehicle having utility to transport high value things (2025-08-26),
4. 12358946 - Method for purifying antibodies (2025-07-15),
5. 12357599 - Prodrugs of treprostinil (2025-07-15),
6. 12310992 - Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells (2025-05-27),
7. 12274684 - Treatment of vasculopathy with prostacyclin and mesenchymal stem cells (2025-04-14),
8. 12173021 - Treprostinil prodrugs (2024-12-24),
9. 12168071 - Treprostinil derivatives and their use in pharmaceutical compositions (2024-12-17),
10. 12162853 - Synthesis of esuberaprost prodrugs (2024-12-10),
11. 12098116 - Crystalline prostacyclin (IP) receptor agonist and uses thereof (2024-09-24),
12. 12097028 - Drug delivery device with electrically controlled volume changing means (2024-09-24),
13. 12022823 - Automated bioreactor system, system for automatically implementing protocol for decellularizing organ, and waste decontamination system (2024-07-02),
14. 12017989 - Controlled release pharmaceutical formulations (2024-06-25),
15. 11839631 - Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells (2023-12-12),
United Therapeutics Corporation is a biotechnology company specializing in the development and commercialization of innovative therapies for patients with rare and chronic diseases. The company focuses on diseases such as pulmonary arterial hypertension, neuroblastoma, and cancer. Through its research and development efforts, United Therapeutics aims to improve the lives of patients around the world. For more information, please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
126 Patents

#1 in Silver Spring, MD

#21 in Maryland

#2,959 in US

#6,174 in the World

...
Silver Spring, MD, United States of America

United Therapeutics Corporation

Forward Citations = 2,573

106 inventors:

goldMedal Hitesh Batra (33 out of 45 patents)

silverMedal Roger Jeffs (22 out of 22 patents)

bronzeMedal Michael Wade (20 out of 21 patents)

4.  Ken Phares (17 out of 17 patents)

5.  David A Walsh (17 out of 20 patents)

Please report any incorrect information to support@idiyas.com
Loading…